Male Infertility Market Research Strategies by Key Drivers, 2023 to 2028

  • Industry Overview of Male Infertility Market

    Male infertility reduces the likelihood of an affected individual's ability to conceive with a fertile woman. This condition can arise due to abnormal sperm function, blockages, or low sperm production, which hinders the delivery of sperm. Factors like genetic defects, undescended testicles, lifestyle choices, diabetes, and infections (such as chlamydia, gonorrhea, mumps, HIV, etc.) are common culprits behind male infertility. Effective treatments for male infertility encompass vasoepididymostomy, hormone therapy, and assisted reproductive technology (ART) procedures like in vitro fertilization (IVF) and varicocele surgery. These interventions work to improve male reproductive health, restore testosterone levels, enhance sperm quality, and facilitate successful pregnancy.

    How Big Is the Male Infertility Market?

    The global male infertility market size reached US$ 3.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach a value of US$ 5.2 Billion by 2028 exhibiting a CAGR of 5.49% during 2023-2028.

    Global Male Infertility Market Trends and Drivers:

    The male infertility market is experiencing notable growth, driven by various factors. The increasing prevalence of delayed pregnancies and evolving lifestyles are key drivers behind this growth. Furthermore, the adoption of DNA fragmentation techniques and computer-assisted semen analysis to diagnose conditions like hypospermia is boosting the market. The rising demand for assisted reproductive technology (ART) procedures, including IVF, which often involve using cryopreserved sperm, is positively impacting the global market. Additionally, government initiatives to enhance reimbursement for infertility treatments and ensure patient data safety contribute to growth. The availability of diverse infertility treatment options, drugs, and devices also plays a role in stimulating the market. Improved healthcare accessibility is expected to further fuel the male infertility market in the forecasted period.

    Key Market Segmentation:

    The report provides detailed segmentation of the global male infertility market based on based on test type, treatment, distribution channel, end user and industry vertical.

    Breakup by Test Type:

    Sperm Agglutination
    DNA Fragmentation Technique
    Oxidative Stress Analysis
    Computer Assisted Semen Analysis
    Sperm Penetration Assay

    Breakup by Treatment:

    Assisted Reproductive Technology and Varicocele Surgery

    Breakup by Distribution Channel:

    Hospitals Pharmacies
    Pharmacies and Drug Stores
    Online Pharmacies

    Breakup by End User:

    Hospitals and Clinics
    Fertility Centers
    Research Institutes

    Breakup by Region:

    North America
    United States
    South Korea
    United Kingdom
    Latin America
    Middle East and Africa

    The report provides a comprehensive analysis of the industry key players listed below:

    The Major Players in the market are Andrology Solutions, CinnaGen Co., Halotech DNA, SCSA Diagnostics Inc., Vitrolife, Zydus Lifesciences Limited, Intas Pharmaceuticals Ltd. and Endo International plc.

Log in to reply